Crinetics Pharmaceuticals (CRNX) EPS (Weighted Average and Diluted) (2020 - 2026)
Crinetics Pharmaceuticals' quarterly EPS (Weighted Average and Diluted) came in at -$1.23 in Q1 2026, down 18.27% year-on-year from -$1.5 in Q1 2025, and up 4.65% quarter-over-quarter from -$1.29 in Q4 2025.
Crinetics Pharmaceuticals has reported EPS (Weighted Average and Diluted) for 7 years, with the latest figure at -$1.23 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) fell 18.27% year-over-year to -$1.23; the trailing twelve-month figure through Mar 2026 stood at -$5.13 (down 34.65% YoY), and the FY2025 full-year result was -$4.95, down 34.15% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at -$1.23, up from -$1.29 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was -$0.73 in Q1 2022, with the low at -$1.38 in Q3 2025.
- Average EPS (Weighted Average and Diluted) over 5 years is -$0.98, with a median of -$0.94 recorded in 2023.
- Year-over-year, EPS (Weighted Average and Diluted) increased 4.95% in 2024 and plunged 48.28% in 2025.
- Tracing CRNX's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.83 in 2022, then dropped by 6.02% to -$0.88 in 2023, then increased by 1.14% to -$0.87 in 2024, then sank by 48.28% to -$1.29 in 2025, then rose by 4.65% to -$1.23 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$1.23 (Q1 2026), -$1.29 (Q4 2025), and -$1.38 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -4.43 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,086.42 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 4.02 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 6.75 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.51 |
| 10 | Crinetics Pharmaceuticals | 3.59 Bn | 3.59 Bn | 10.53 Mn | -1.23 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.23 |
| Dec 31, 2025 | -1.29 |
| Sep 30, 2025 | -1.38 |
| Jun 30, 2025 | -1.23 |
| Mar 31, 2025 | -1.04 |
| Dec 31, 2024 | -0.87 |
| Sep 30, 2024 | -0.96 |
| Jun 30, 2024 | -0.94 |
| Mar 31, 2024 | -0.93 |
| Dec 31, 2023 | -0.88 |
| Sep 30, 2023 | -1.01 |
| Jun 30, 2023 | -0.94 |
| Mar 31, 2023 | -0.85 |
| Dec 31, 2022 | -0.83 |
| Sep 30, 2022 | -0.78 |
| Jun 30, 2022 | -0.81 |
| Mar 31, 2022 | -0.73 |
| Dec 31, 2021 | -0.80 |
| Sep 30, 2021 | -0.73 |
| Jun 30, 2021 | -0.70 |
| Dec 31, 2020 | -0.71 |